A Multi-center, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase I/II Clinical Study to Evaluate Safety and Efficacy of Allogeneic Adipose-derived Stem Cells for the Treatment of Lateral Epicondylitis
Phase of Trial: Phase I/II
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Tennis elbow
- Focus Adverse reactions; Therapeutic Use
- Sponsors Anterogen
- 22 Nov 2016 Status changed from active, no longer recruiting to completed.
- 08 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 08 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.